FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
- FDA: 31 events in the last 90 days
- Previous: earlier the same day · FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
What happened
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
Summary assembled by rule from the sources below